Hospital systems will be in a precarious position if they all aim for the same North Star. What might their evolution look like in coming years?
Natural language processing is the perfect example of how AI can maximize people's talents, impact, and value. But its potential is just being realized.
A detailed look at the 22 new payer-provider partnerships created in Q1 this year.
Why a focus on the provider is needed to achieve 4 or 5 Stars.
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.
2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.
Earlier this year, we analyzed payer-provider partnerships. As 2017 comes to a close, we consider the year's steady growth and new twists.
Based on our analysis recently featured in the Wall Street Journal, the prevalence of no cost bronze coverage has increased significantly for 2018.
As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.
Survey responses confirm that CSR defunding would have a significant impact on 2018 rates and payers’ continued participation in the ACA exchanges.